TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06531031: Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples

Sponsor: Microbio Co Ltd · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 1500 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$9,408,000

Rescue Site Savings

+$6,203,400

Unlock Full NCT06531031 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06531031 Rescue Dossier →